Streptokinase biosimilar (Pharmacia & Upjohn)

链激酶生物类似药 (Pharmacia & Upjohn)

Report date: 2026/03/26 20:00:17

Base Information

Drug NameStreptokinase biosimilar (Pharmacia & Upjohn)
Drug Alias NameKABIKINASE
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeBiologics > Biosimilar
Mechanisms of ActionPlasminogen activators
TargetsPlasminogen
Therapy Area/IndicationsVenous ThromboembolismMyocardial InfarctionPulmonary Embolism
Global Approved IndicationsVenous ThromboembolismMyocardial InfarctionPulmonary Embolism
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCanada
Original Approved Date1995/12/31
Country/TerritoryCanada
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPharmacia & UpjohnPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacia & Upjohn
Active IndicationsN/A
Inactive IndicationsVenous ThromboembolismMyocardial InfarctionPulmonary Embolism

Other Information

ATC CodeN/A
Related LinksN/A